ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Ansible Automation Platform Engineer – Linux Infrastructure (SME) at Eli Lilly and Company - ApplyBlast

Ansible Automation Platform Engineer – Linux Infrastructure (SME)

Eli Lilly and Company

2 months ago

4.0 on Glassdoor

Bengaluru, Karnataka, India

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The role leads the design, implementation, and management of enterprise Linux platforms across on‑premises, public cloud, and hybrid environments, driving automation through the Ansible Automation Platform. The engineer will own Linux as a Service, ensure security, compliance, and high‑availability, and mentor teams while collaborating with cross‑functional stakeholders.

Responsibilities

Lead design, implementation, and management of enterprise Linux platforms
Develop and maintain Ansible Automation Platform content and IaC pipelines
Ensure security, compliance, and high‑availability across hybrid cloud environments

Skills

Qualifications

Red Hat Certified Specialist in Ansible AutomationRed Hat Certified Engineer (RHCE)Kubernetes/OpenShift certificationRed Hat Certified Architect (RHCA)ITIL certification

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.